Oporto, Portugal

Patricio Manuel Viera Araujo Soares Da Silva


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Patricio Manuel Viera Araujo Soares Da Silva: Innovator in Pharmaceutical Chemistry

Introduction

Patricio Manuel Viera Araujo Soares Da Silva is a notable inventor based in Oporto, Portugal. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the treatment of nervous system disorders. His innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Patricio holds a patent for "Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them." This patent represents a significant advancement in the treatment options available for patients suffering from various nervous system disorders.

Career Highlights

Patricio is currently employed at Portela & Ca., S.A., a company known for its commitment to pharmaceutical innovation. His work at the company has allowed him to focus on developing new therapeutic solutions that can improve patient outcomes. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Patricio has collaborated with esteemed colleagues, including Jan Benes and David Alexander Learmonth. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared goals in pharmaceutical research.

Conclusion

Patricio Manuel Viera Araujo Soares Da Silva exemplifies the spirit of innovation in the pharmaceutical field. His contributions through his patent and work at Portela & Ca., S.A. highlight the importance of research in developing effective treatments for nervous system disorders. His ongoing efforts continue to inspire advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…